Prg Science & Technology Co., Ltd.

This study aims to test the safety and tolerability of an experimental drug called progerinin in adults with Werner syndrome, a rare genetic condition that causes premature aging. Up to five participants will take the drug twice daily for one year to see if it can help slow the l…

This early-stage study is testing a new oral medication called PRG-N-01 for adults with Neurofibromatosis Type II (NF2), a genetic condition that causes non-cancerous tumors along nerves. The main goals are to find the safest and most effective dose and to see if the drug can shr…